BioCentury | Dec 1, 2006
Financial News

Xanthus raises $25 million

...current tranche included Oxford Bioscience Partners; HealthCare Ventures; GeneChem; GIMV; Hambrecht & Quist Capital Management; Still River Fund...
BioCentury | Dec 15, 2003
Finance

Ebb & Flow

...Capital-Technology Ventures; Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda; Still River Fund...
BioCentury | Dec 12, 2003
Financial News

Xanthus raises $30.8 million

...Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda.; HealthCare Ventures; Still River Fund...
BioCentury | Apr 4, 2001
Financial News

U.S. Genomics raises $17 million

...DNA, raised $17 million in a private round. Investors included HealthCare Ventures; CB Health Ventures; Still River Fund...
Items per page:
1 - 4 of 4
BioCentury | Dec 1, 2006
Financial News

Xanthus raises $25 million

...current tranche included Oxford Bioscience Partners; HealthCare Ventures; GeneChem; GIMV; Hambrecht & Quist Capital Management; Still River Fund...
BioCentury | Dec 15, 2003
Finance

Ebb & Flow

...Capital-Technology Ventures; Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda; Still River Fund...
BioCentury | Dec 12, 2003
Financial News

Xanthus raises $30.8 million

...Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda.; HealthCare Ventures; Still River Fund...
BioCentury | Apr 4, 2001
Financial News

U.S. Genomics raises $17 million

...DNA, raised $17 million in a private round. Investors included HealthCare Ventures; CB Health Ventures; Still River Fund...
Items per page:
1 - 4 of 4